JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Right arrow Help viewing high resolution images
Right arrow Return to article
Click on image to view larger version.



FIGURE 1. (A) Upper and lower panels represent transverse CT, SPECT, and hematoxylin and eosin histology of somatostatin receptor (SSR)-positive tumor 2 and SSR-negative tumor 1, respectively, in patient 1, after 4 cycles of PRRT. (B) Sizes of 4 hepatic lesions after PRRT with somatostatin analog ({blacktriangleup}). Tumors above stippled line were not seen on octreotide scan, nor were the 2 tumors below this line; one of each was biopsied and depicted in (A).





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE